As per our report, the size of the global microbiome sequencing services market was around USD 722.93 Million in 2020. The market is showcasing a remarkable a CAGR of 21.5% to reach USD 1914.6 Million by 2025.
Microbiome sequencing is used to evaluate the human biodata to understand the illness with different methods. Microbiome sequencing service can help to diagnose & treat chronic diseases. USFDA play a vital role in the microbiome sequencing service market; they take responsibility to deliver safety and efficacy. FDA examines the part of the microbiome in the antimicrobial resistance in humans also in animals.
MARKET DRIVERS
Rising demand for Next-generation sequencing, expansion of microbiome sequencing service application and reduction in the cost of Sequencing are the factors driving the market growth. The increasing scale of pharmaceutical industries, growing awareness and benefits of microbiome sequencing for cancer treatment are fueling the market. The rise in the incidences of chronic diseases is significantly influencing the demand of the market.
The growth of the global microbiome sequencing services market is further driven by the rise in the research and development institutes in the biological field, growing studies over genomics and increasing incidences of chronic diseases.
Additionally, increasing spending on health care in urban areas and growing support from the government through investments are fuelling the demand for the microbiome sequencing services market. Also, rising priority for early diagnosis as some diseases may have a complete cure when diagnosed at the starting stage is driving the demand for the market.
MARKET RESTRAINTS
However, the lack of skilled persons in operating systems is quietly is the biggest challenge hampering the growth of the market. Stringent rules and regulations by the government and the cost for the installation and maintenance of the equipment is a little high. These are further expected to limit the growth of the global microbiome sequencing services market.
Lack of innovation with intensive analysis can hamper the market growth. The less number of technicians, physicians and scientists are slowly limiting the growth rate of the market. High of equipment in laboratories is also impeding the growth rate of the market.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Analyzed |
By Technology, Application, Research type, Laboratory Type and End User |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
This research report on the global microbiome sequencing services market has been segmented based on the technology, application, research type, laboratory type and end-user.
Microbiome Sequencing Services Market – By Technology
Based on technology, Sequencing by synthesis technique is growing at a higher rate from the past few years, and it is to continue the same flow in the forecast period. Adoption of advanced technology is levelling up the growth rate of the market.
Microbiome Sequencing Services Market – By Application
Based on application, the shotgun sequencing application is witnessed in leading dominant shares of the market. Increasing prevalence to ensure effective treatment procedures is magnifying the demand of the business. The shotgun is being quicker and cheaper than any other methods which are propelling the growth rate of the market.
Microbiome Sequencing Services Market – By Research type
Based on the research type, the outsourced research drug segment occupies the largest share and grows with the highest CAGR value in the microbiome sequencing services market.
Microbiome Sequencing Services Market – By Laboratory type
Based on the laboratory type, the wet lab segment is expected to hold the largest share and grow with highest CAGR value over the forecast period.
Microbiome Sequencing Services Market – By End-user
Based on end-user, the pharmaceutical companies are ruling revenue shares of the market. The growing number of healthcare centres is prompting the growth of the market extensively. The increase in funds by government and other private organizations for research and development of the market.
Regional Insights:
In 2019, the global microbiome sequencing services market was held by North America due to the rise in the economy in most of the countries. Factors like funds and investments from government and advance technologies and increasing research activities are majorly propelling the market growth in this region. The U.S. is the leading nation of this region, due to the government research in genomics along with different government bodies.
The Asia Pacific is positioned second in leading the highest shares of the market by owing to the launch of innovative techniques in diagnosing the disease. Asia-Pacific is the quickest growing region with a high CAGR value for the next coming years. The growth of this region is attributed due to steady developments of sequencing technologies, and launch of new techniques for diagnosing the diseases.
Europe region is expected to showcase promising growth during the forecast period with the rise in the number of genetic disorders. Increasing preference for self-medication is levelling up the growth of the market. The growth of this region is attributed due to rising usage of micro-biomes in genomics, proteomics and metabolomics. Also, factors like non-appearance of adequate regulations, government directions are hampering the growth. U.K and Germany are dominating with the highest shares of the market. Existence of significant players and growing awareness towards NGS are vital factors boosting up the growth rate.
Latin America region has steady growth in the market share compared with other areas of microbiome sequencing services market. The increase in this region is attributed due to rise in the support from the government through investments.
At the same time, Middle East & Africa has also got a meager share of the microbiome sequencing services market. On-going research and development activities on genomic and growing occurrences of chronic diseases are estimated to fuel the market growth.
TOP COMPANIES IN THE MARKET
List of key companies dominating the Global Microbiome Sequencing Services Market profiled in the report is Microbiome Insights Inc., Rancho Biosciences, Zymo Research Corp., Molzym GmbH & Co., Ubiome Inc., Diversigen Inc., Merieux Nutrisciences Corporation and Molecular Research LP.
RECENT MARKET DEVELOPMENTS
On January 2019, Ora Sure technologies, Inc. announced the acquisition of CoreBiome. CoreBiome bioinformatics platform gives benefits to the researcher with a high resolution of DNA Sequencing by thousands of microbiome samples.
On August 29, 2019, Cr, Hansen Holding A/S signed the agreement with Lonza AG, a leading pharmaceutical company of contract manufacturing. This joint venture leads to develop biotherapeutic products.
On September 2018, Prescient Medicine Holdings, LLC & Metabiomics Corporation announced the joint venture for the development of innovative microbiome diagnosis platform. It can detect the precancerous colon Polyps & diagnosing types of gastrointestinal diseases. This technique specially designed for healthcare practitioners.
On June 2018, CooreBiome launched the shotgun metagenomically. This new service gives high-quality gene profiling for human microbiome deep characterization. Shotgun sequencing starts in-depth 2 million sequences/sample.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technology
5.1.1 Introduction
5.1.2 sequencing by synthesis
5.1.3 sequencing by ligation
5.1.4 pyrosequencing
5.1.5 sanger sequencing
5.1.6 Other technologies
5.1.7 Y-o-Y Growth Analysis, By Technology
5.1.8 Market Attractiveness Analysis, By Technology
5.1.9 Market Share Analysis, By Technology
5.2 Application
5.2.1 Introduction
5.2.2 shotgun sequencing
5.2.3 targeted gene sequencing
5.2.4 RNA sequencing
5.2.5 whole genome sequencing
5.2.6 Other applications
5.2.7 Y-o-Y Growth Analysis, By Application
5.2.8 Market Attractiveness Analysis, By Application
5.2.9 Market Share Analysis, By Application
5.3 Research type
5.3.1 Introduction
5.3.2 Internal research
5.3.3 Outsourced researchDrug
5.3.4 Y-o-Y Growth Analysis, By research type
5.3.5 Market Attractiveness Analysis, By research type
5.3.6 Market Share Analysis, By research type
5.4 Laboratory type
5.4.1 Introduction
5.4.2 Wet lab
5.4.3 Dry lab
5.4.4 Y-o-Y Growth Analysis, By Laboratory type
5.4.5 Market Attractiveness Analysis, By Laboratory type
5.4.6 Market Share Analysis, By Laboratory type
5.5 End user
5.5.1 Introduction
5.5.2 Pharmaceutical
5.5.3 Biotechnology
5.5.4 Y-o-Y Growth Analysis, By End user
5.5.5 Market Attractiveness Analysis, By End user
5.5.6 Market Share Analysis, By End user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Application
6.1.3.4 By Research type
6.1.3.5 By laboratory type
6.1.3.6 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technology
6.1.4.3 By Application
6.1.4.4 By Research type
6.1.4.5 By laboratory type
6.1.4.6 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Application
6.1.5.4 By Research type
6.1.5.5 By laboratory type
6.1.5.6 By End user
6.2 North America
6.2.1 Introduction
6.2.2 United States
6.2.3 Canada
6.3 Europe
6.3.1 Introduction
6.3.2 U.K
6.3.3 Spain
6.3.4 Germany
6.3.5 Italy
6.3.6 France
6.4 Asia-Pacific
6.4.1 Introduction
6.4.2 China
6.4.3 India
6.4.4 Japan
6.4.5 Australia
6.4.6 South Korea
6.5 Latin America
6.5.1 Introduction
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Rest of Latin America
6.6 Middle East & Africa
6.6.1 Introduction
6.6.2 Middle-East
6.6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Metabiomics Corp
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Microbiome Therapeutics LLC
8.3 Microbiome Insights Inc.
8.4 Rancho Biosciences
8.5 Zymo Research Corp
8.6 Molzym GmbH & Co.
8.7 Celgene Corporation
8.8 Ubiome Inc.
8.9 Diversigen Inc.
8.10 Merieux Nutrisciences Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
